News

Roche announced that the U.S. FDA granted accelerated approval to Venclexta™ (venetoclax) for the treatment of people with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior...

Experimental “Internet of Things” System Uses Connected Devices to Enable Remote Measurement of Health and Quality of Life in Real-Time.Multi-Year Project Could Potentially Change How Clinical Trials are Conducted. Pfizer Inc and IBM announced a first-of-its-kind...

Sandoz, a Novartis division and the global leader in biosimilars, announced that the European Commission (EC) has approved a type II variation for the addition of a subcutaneous (s.c.) route of administration in Binocrit's® (epoetin alfa) nephrology indication. ...

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Valganciclovir Tablets USP, 450 mg. This product is to be launched in Q1...

Clinicians will soon have access to patient’s complete medical record for the first time InterSystems, a global leader in health information technology, today announced a partnership with Lincolnshire Health and Care (LHAC) that will help LHAC...

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced today that 17 abstracts will be presented at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16), to be held April 2-4 in Chicago, IL. ...

"We are eager to continue to extend the use of Opdivo as a treatment option and potentially provide hematology with its first PD-1 inhibitor, a type of treatment that is designed to work with the PD-1 pathway and leverage...